According to the agreement, American Healthcare Products will distribute Injex 30 in Washington state, California, Arizona, Nevada and Oregon and the agreement also includes a fixed minimum volume
Boehringer Ingelheim Pharmaceuticals clinical development and medical affairs senior vice president John Smith said with FDA decision, Tradjenta can be an effective add-on therapy with a demonstrated safety
Actos is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. According to IMS
ACTOplus met is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. According to
The current Phase 2 AbGn-168H trial will be a multicenter, placebo-controlled, double-blind trial with the primary objective to demonstrate that AbGn-168H provides safe, durable, and remissive therapeutic effect
PerkinElmer Informatics general manager Michael Stapleton said as chemists are turning to electronic laboratory notebooks to plan, execute and record their experiments, they also need ready access to
Previously, FDA has also approved the company’s ANDA for Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets, 15mg/500mg and 15mg/850mg. The FDA has granted Mylan 180 days of generic marketing
The ¥4.2bn ($53m) building is expected to improve Astellas’ capacity to manufacture investigational drug substance used in high pharmaceutical activities. The Building No. 8 will have seven stories
The patent covers the methods and compositions to treat cancer using oncolytic Respiratory Syncytial Virus or (RSV) activity. The agreement, in conjunction with the US and worldwide patents
As part of the collaboration, the companies will develop TGR-1202 on a worldwide basis, excluding India, in the areas of hematologic malignancies and autoimmune disease. Rhizen will also
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.